Chest Infections
-
AI-enabled approaches poised to transform diagnosis, management of lung diseases
Experts explore how AI-based tools can be used to bridge diagnostic challenges and address unmet needs in chronic respiratory disease care.
-
Patients with COPD, bronchiectasis experience sex-based disparities in care
Radmila Choate, PhD, MPH, and her team sought to capture “lived experiences in a way that helps clinicians recognize patterns that differ for women and men and adapt care more thoughtfully.”
-
Study shows glucocorticoids cut mortality in community acquired pneumonia in low-income settings
Anthony O. Etyang, MBChB, MMed, MSc, PhD, said recent data bolster the evidence that steroids may be useful for severe pneumonia in high-income settings as well.
-
Trials suggest RSV vaccine reduces hospitalization for cardiorespiratory conditions in older adults
Data from studies in the United States and Denmark add to the growing evidence that respiratory syncytial virus (RSV) vaccination is effective in older adults.
-
Oseltamivir found to lower risk of flu-linked neuropsychiatric events in children
This study is the largest and most comprehensive US investigation of the drug and severe neuropsychiatric events, said author James Antoon, MD, PhD, MPH.
-
Data suggest pneumococcal vaccination is underused
Respiratory medicine expert Christina Thornton, MD, PhD, said recent real-world data demonstrate high rates of community-acquired pneumonia driven by serotypes targeted by vaccines.
-
Clinicians share advice for working with vulnerable patient populations
Laura J. Spece, MD, MSc, spoke about specific respiratory health concerns for US military veterans during a session that also focused on optimizing care for patients who are transgender, patients shifting from pediatric to adult care, and patients with limited language proficiency.
-
Case discussions to address complexities of mediastinal lymphadenopathy diagnosis
Sebastian Kurz, MD, PhD, FCCP, will chair a Wednesday afternoon panel session that will guide attendees through imaging findings, differential diagnoses, and clinical decision-making in mediastinal lymphadenopathy.
-
Experts discuss advances in understanding, management of chronic cough
Sumera Ahmad, MBBS, discussed pharmacological innovations for chronic cough, including P2X3 antagonists, opiates, and neuromodulators.
-
Panel to introduce new CHEST North American bronchiectasis guidelines
Ashwin Basavaraj, MD, FCCP, will chair a Tuesday afternoon session summarizing CHEST’s North American bronchiectasis guidelines, their development process, and a case-based scenario for implementing their recommendations.
-
90th anniversary sessions to reflect on past, present, and future of field
Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.
-
Panel to outline growing impact of climate change in critical care
Stephanie Maximous, MD, MS, will chair a Sunday morning session on climate change’s growing encroachments in critical illness and acute conditions such as heart attacks, strokes, and asthma exacerbations.
